Navigation Links
Hormone may hold key to helping elderly men live longer
Date:5/27/2008

Elderly men with higher activity of the hormone IGF-1or insulin-growth factor 1appear to have greater life expectancy and reduced cardiovascular risk, according to a new study accepted for publication in the Journal of Clinical Endocrinology & Metabolism (JCEM).

IGF-1 is a hormone similar in molecular structure to insulin. It is released from the liver and plays an important role in childhood growth and continues to have anabolic effects in adults.

In this study, researchers evaluated 376 healthy elderly men between the ages of 73 and 94 years. A serum sample was taken from each subject at the beginning of the study and researchers were contacted about the status of the participants over a period of eight years.

Subjects with the lowest IGF-1 function had a significantly higher mortality rate than subjects with the highest IGF-1 bioactivity. These results were especially significant in individuals who have a high risk to die from cardiovascular complications.

These new findings come as a result of a new form of testing for IGF-bioactivity. Researchers in this study used a new method, a bioassay, to measure the function of IGF-1 in the blood. Compared to commonly used methods to measure IGF-1, the IGF-1 bioassay gives more information about the actual function (bioactivity) of circulating IGF-1 in the body.

The bioassay allowed us to more clearly see the association between high circulating IGF-1 bioactivity and extended survival, said Michael Brugts, MD, of the Erasmus Medical Center in Rotterdam, The Netherlands and lead author of the study. Interestingly, we could not find such a relationship when IGF-1 in blood was measured with the more commonly used methods.

Immunoassays, commonly used previously to determine IGF-1 circulation levels, remove certain proteins that interfere with accurate measurements. Recent studies however have found that these proteins are important modulators of IGF-1 bioactivity. The bioassay used in this study does not disregard or remove this protein, thus enabling researchers to have a more accurate understanding of IGF-1 function.

Determination of IGF-1 function using the bioassay opens the possibility to gather new insights about the functions of IGF-1 in the body, said Brugts.


'/>"/>

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Source:Eurekalert

Related medicine news :

1. Blood cholesterol levels predict risk of heart disease due to hormone therapy
2. Hormone Therapy Safe, Effective for Women Entering Menopause
3. Patients, Doctors, Pharmacists Praise Bipartisan House Resolution on Compounded Hormones Containing Estriol
4. Hunger Hormone Makes Food Look More Tasty
5. Heart Hormone Elevated in Children Who Wet Bed
6. Pituitary Hormone May Boost Womens Heart Risk
7. Womens biological clock revealed: Hormone may predict age at menopause
8. ENDO 08: Latest news on hormones, steroids, obesity, diabetes and more
9. Growth Hormone is Used to Treat Twice as Many Short Boys Than Girls in the U.S. and Asia; Gender Difference is Smaller in the Rest of the World
10. Growth hormone is used to treat twice as many short boys than girls in the US and Asia
11. Hormone Replacement May Cut Risk for Age-Linked Eye Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2017)... ... May 29, 2017 , ... Thomas Dickerson, ... is the new president of the Board of Directors for the Radiology ... administrators. He succeeds outgoing Board President Jim Hamilton, MHA, CMM, FRBMA, an administrator ...
(Date:5/28/2017)... ... 2017 , ... HYPERAMS, LLC announced it will perform the inventory ... Lima, Ohio. The sale began this week and the inventory is expected to sell ... uniforms, and medical accessories, including blood pressure cuffs, stethoscopes, CPR masks, as well as ...
(Date:5/27/2017)... Angeles, California (PRWEB) , ... May 26, 2017 , ... ... senior citizens who visit a doctor for colds or respiratory issues that are not ... that excessive time pressure on doctors may be largely responsible for the problem both ...
(Date:5/27/2017)... (PRWEB) , ... May 27, 2017 , ... Most us ... concern, but a new study from the Osteoarthritis Initiative shows that certain ... knee osteoarthritis. Knowing this in advance may give doctors the opportunity to treat patients ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... ... to announce a new educational seminar to focus on current legislative activity and ... seminar will begin at 1 p.m. Sunday, Sept. 10, and will continue through ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... , May 10, 2017 Radiology has become ... its costs have also spiraled to the number one ... to radiology than ever before as the most complete ... a patient with lower back pain an MRI may ... reason for pain, resulting in entirely different treatment protocols.  ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
(Date:5/6/2017)... 2017   Provista , a proven leader in the ... today announced Jim Cunniff as the company,s new ... business experience to Provista, including most recently serving as the ... California . He assumed his new role with Provista ... fit for Provista," says Jody Hatcher , president, Sourcing ...
Breaking Medicine Technology: